FURIEX PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
FURIEX PHARMACEUTICALS, INC. reported Share-based Payment Arrangement, Expense of $5.30 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2014-03-17
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2013-03-31 was $2.50M, a 47.06% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2012-12-31 was $1.30M, a 8.33% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2012-09-30 was $1.20M, a 71.43% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2012-06-30 was $1.30M, a 18.75% decline year-over-year.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2013 was $5.30M, a 3.64% decline from fiscal 2012.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2012 was $5.50M, a 30.95% increase from fiscal 2011.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2011 was $4.20M, a 250.00% increase from fiscal 2010.
- FURIEX PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2010 was $1.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2013-12-31 | $5.30M 10-K · filed 2014-03-17 | |||
| 2013-03-31 | $2.50M 10-Q · filed 2013-05-09 | $3.80M derived: sum of 2 quarters · filed 2014-03-17 | $5.00M derived: sum of 3 quarters · filed 2014-03-17 | $6.30M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $2.50M derived: sum of 2 quarters · filed 2014-03-17 | $3.80M derived: sum of 3 quarters · filed 2014-03-17 | $5.50M 10-K · filed 2014-03-17 |
| 2012-09-30 | $1.20M 10-Q · filed 2012-11-06 | $2.50M derived: sum of 2 quarters · filed 2012-11-06 | $4.20M 10-Q · filed 2012-11-06 | $5.40M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $1.30M 10-Q · filed 2012-08-07 | $2.90M 10-Q · filed 2012-08-07 | $4.20M derived: sum of 3 quarters · filed 2014-03-17 | $4.90M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $1.70M 10-Q · filed 2013-05-09 | $2.90M derived: sum of 2 quarters · filed 2014-03-17 | $3.60M derived: sum of 3 quarters · filed 2014-03-17 | $5.20M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.90M derived: sum of 2 quarters · filed 2014-03-17 | $3.50M derived: sum of 3 quarters · filed 2014-03-17 | $4.20M 10-K · filed 2014-03-17 |
| 2011-09-30 | $700.00K 10-Q · filed 2012-11-06 | $2.30M derived: sum of 2 quarters · filed 2012-11-06 | $3.00M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $1.60M 10-Q · filed 2012-08-07 | $2.30M 10-Q · filed 2012-08-07 | ||
| 2010-12-31 | $1.20M 10-K · filed 2013-03-18 |